Related Experiment Video
Updated: May 9, 2026
07:40
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
Using linked data for mining drug-drug interactions in electronic health records
Jyotishman Pathak1, Richard C Kiefer, Christopher G Chute
1Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Studies in Health Technology and Informatics
|August 8, 2013
Summary
Semantic Web and Linked Data technologies can identify potential drug-drug interactions (PDDIs) from electronic health records (EHRs). This approach aids in understanding patient outcomes and supports personalized, genome-guided therapies.
Area of Science:
- Health Informatics
- Bioinformatics
- Semantic Web Technologies
Background:
- Healthcare data is complex and voluminous, offering opportunities to discover relationships between treatments and patient outcomes.
- Representing and querying large network datasets, such as those in electronic health records (EHRs), presents significant technical challenges.
- Identifying drug-drug interactions (DDIs) is crucial for patient safety and effective treatment.
Purpose of the Study:
- To investigate the application of Semantic Web and Linked Data technologies for identifying drug-drug interaction (DDI) information.
- To determine if identified DDIs are observed in real patient data from electronic health records (EHRs).
- To explore the potential for genome-guided drug therapies and personalized treatment interventions.
Main Methods:
- Utilized Semantic Web and Linked Data principles for data representation.
- Applied Resource Description Framework (RDF) to represent patient data from Mayo Clinic's EHRs.
- Identified potential drug-drug interactions (PDDIs) for cardiovascular and gastroenterology medications.
Main Results:
- Demonstrated the feasibility of using Linked Data to represent complex EHR data.
- Successfully identified potential drug-drug interactions (PDDIs) for commonly prescribed drugs.
- Proof-of-concept study highlighted the methodology's potential for clinical applications.
Conclusions:
- Semantic Web and Linked Data technologies offer a powerful framework for analyzing complex healthcare data.
- This approach can effectively identify potential drug-drug interactions (PDDIs) within real-world patient data.
- The methodology supports advancements in studying patient health outcomes and enabling personalized medicine.
Related Concept Videos
01:25Pharmacokinetics: Drug–Drug Interactions
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
01:30Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
01:29Drug-Receptor Interactions
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
01:29Issues And Trends In Healthcare Delivery System
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
01:24Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
01:30Quantitative Aspects of Drug-Receptor Interaction
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower Kd...